B
Biodesy
Biodesy is developing technology to directly measure both changes in protein shape and function in real time
About Biodesy
Biodesy, Inc., now operating as BlueLight Therapeutics, is a venture-funded company established in 2013 that specializes in the development and manufacturing of cutting-edge bioanalytical instruments and reagents. These tools are designed to measure protein structural changes, which are critical in the drug discovery process. The company primarily serves pharmaceutical and biotechnology firms engaged in small molecule hit discovery. Biodesy's proprietary technology enables precise measurement of protein structural changes, facilitating the identification of potential drug candidates. The business operates in the bioanalytical research market and generates revenue through the sale of its instruments and reagents, as well as through collaborative research agreements. The company is based in South San Francisco, CA, and is known for its innovative approach and high-growth potential. Key clients include research institutions and pharmaceutical companies focused on drug development.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2000
- Headquarters
- South San Francisco, United States
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 86.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Sep 2018 | $20M | $80M | Pfizer Ventures | — |
| SERIES B✓Equity / VC | Jan 2016 | $10M | $40M | 5AM Ventures · Roche Venture Fund | — |
Growth signals
Latest recorded traffic for Biodesy is 1.1K monthly website visits, up 205.6% over the last three months. Biodesy's team grew 50% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- PVPfizer Ventures
Series A2 investors entered at this stage
5AM Ventures
Roche Venture Fund
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biodesy on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biodesy’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.